Medtronic has earned a CE mark for the Guardian Connect mobile continuous glucose monitoring system for individuals with diabetes who use insulin injection therapy.

“Having continuous, real-time access to glucose values and being alerted to important trends and events is key for people with diabetes,” said Annette Brüls, president of diabetes service and solutions at Medtronic.